Modified Amniotic Fluid Score With Fetal Bladder Assessment
NCT ID: NCT07315243
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
70 participants
OBSERVATIONAL
2026-01-31
2027-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Amniotic Fluid Lamellar Body Count and Fetal Pulmonary Artery Doppler Indices in Predicting Fetal Lung Maturity
NCT02331199
Pivotal Study of the Rx Al-Sense Liner for Amniotic Fluid Leakage Screening
NCT02959268
Study of a Diagnostic Device for Identifying Between Amniotic Fluid to Urine
NCT01517633
Comparison of Amniotic Fluid Index Between Before and After Maternal Position Change in Upright and Left Lateral Decubitus Position
NCT03536689
Biophysical Profile in Preterm Pregnancies
NCT02561364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Eligible participants will undergo a standardized ultrasound examination using a high-resolution machine with a curvilinear transducer; the uterus will be systematically scanned to obtain AFI and single deepest pocket measurements, followed by a dedicated five-minute assessment of the fetal bladder to document its size, appearance, and any observed micturition events. All sonographic assessments will be performed by experienced sonographers following uniform protocols, and approximately 10 percent of examinations will be re-scanned by a second sonographer to assess interobserver reliability, with images and measurements digitally archived for blinded review.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton pregnancy between 20 and 38 weeks of gestation.
* Women attending Assiut University Hospital for routine or indicated ultrasound assessment of amniotic fluid volume.
* No known major fetal anomalies at the time of inclusion.
* Able and willing to provide written informed consent.
Exclusion Criteria
* Pregnancies with known chromosomal or major structural fetal anomalies diagnosed prior to enrollment.
* Maternal systemic diseases known to affect amniotic fluid volume (e.g., pregestational or gestational diabetes, chronic hypertension, renal disease).
* Contraindications to ultrasound examination.
* Inability to provide informed consent or anticipated poor compliance with study procedures.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Salah Eldin Ali Hassan
Resident at Obstetrics and Gynecology Department, Assiut University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Modified Amniotic Fluid Score
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.